In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Merz acquires third aesthetics company within a year, pays $600mm for Ulthera

Executive Summary

In its largest acquisition to date, and the third within a year in the aesthetics field, Merz North America Inc. (part of German drug company Merz GMBH & Co. KGAA’s Merz Pharma Group) will pay $600mm in up-front and earn-out payments for privately held Ulthera Inc.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Earnout
    • Payment Includes Cash

Related Companies